A 51-year-old man got a dexamethasone implant in his eye to treat uveitis, a condition where the eye becomes inflamed. The implant is a tiny pellet that slowly releases a steroid. But later, he developed endophthalmitis, a serious infection inside the eye. Doctors identified the bacteria as Staphylococcus epidermidis. They also found it made up 99.96% of the bacterial reads in his eye, based on 24,904 genetic reads. This was a delayed-onset infection, meaning it didn't show up right away. The man had surgery to remove the implant and the infection, but the infection came back. This is a case report, which means it's just one person's story. It's not proof that this happens often or that the implant is unsafe for everyone. The report suggests that when these infections happen, they can be stubborn and may need systemic antibiotics to fully clear. His vision improved to 20/33, but the road was rough. If you have an eye implant and notice new pain, redness, or vision changes, talk to your doctor right away.
Intravitreal dexamethasone implants can lead to delayed-onset and recurrent infectious endophthalmitisA Steroid Eye Implant Led to a Rare Infection That Came Back
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This case report describes a single instance of endophthalmitis in a 51-year-old male following the administration of an intravitreal dexamethasone implant. The patient also presented with uveitis and cystoid macular edema. The primary pathogen identified was Staphylococcus epidermidis, which showed a 99.96% relative abundance across 24,904 reads.
The clinical course was complicated by a delayed-onset and recurrent infection. Despite the surgical removal of the implant, the infection persisted. The patient's best-corrected visual acuity was recorded as 20/33. The authors note that infections following corticosteroid implants may present with delayed onset and can recur even after complete surgical removal.
A key clinical takeaway is that systemic antimicrobial therapy may be necessary to eradicate residual infection in these cases. Due to the nature of this report, the evidence is limited to a single case and does not provide a basis for broad clinical guidelines, but it serves as a warning regarding the potential for persistent infection following steroid implant placement.
How this fits prior evidence
This case report addresses a gap in clinical awareness regarding the complications of intravitreal corticosteroid implants. While previous reports have highlighted the efficacy of dexamethasone in other contexts, such as improving clinical efficacy in subacute thyroiditis, this case specifically highlights the risk of delayed-onset and recurrent infection following its use in the eye. It does not relate to the previously covered findings regarding P-GemOxD, pediatric empyema, MACS, or Propofol.
Common questions
What is endophthalmitis?
Endophthalmitis is a serious infection inside the eye. It can cause pain, redness, and vision loss. In this case, it happened after a steroid implant. The infection was caused by Staphylococcus epidermidis, a common bacterium. It was delayed-onset, meaning it didn't appear right away. This is a rare but serious complication.
Can the infection come back after surgery?
Yes, in this case report, the infection returned even after the implant was completely removed. The man needed more treatment, including systemic antimicrobial therapy. This shows that these infections can be stubborn and may require ongoing care. If you have eye symptoms after surgery, tell your doctor.
What are the symptoms of an eye infection after an implant?
The report doesn't list specific symptoms, but endophthalmitis typically causes eye pain, redness, swelling, and vision changes. In this case, the man's vision improved to 20/33 after treatment. If you notice any new or worsening eye symptoms after an implant, contact your doctor immediately.
Is this a common complication of steroid eye implants?
This is a single case report, so it doesn't tell us how common this complication is. It's a rare event, but it can happen. The report highlights that delayed-onset and recurrent infections are possible. Always discuss risks and benefits with your doctor before any procedure.
More on uveitis
View Original Abstract ↓
SGLT2 inhibitors reduce risk of diabetic retinopathy progression (rr 0.77) and macular edema progression (rr 0.75)
SGLT2 inhibitors show promise in slowing diabetic eye disease
Related in Ophthalmology
From Other Specialties
